Chronic Cough Market (2020 - 2027): Key Manufacturers, Development Trends and Competitive Analysis | NovartisAG, CiplaInc., MylanN.V., AurobindoPharma Ltd

According to our new marketresearch study titled the global chronic cough market is expected to reachUS$ 9,854.8 million by 2027 from US$ 5,430.0 million in 2019; it is estimatedto grow at a CAGR of 7.8% from 2020 to 2027.

Novartis AG; TevaPharmaceutical Industries Ltd; GlaxoSmithKline plc; Bayer AG; Mylan N.V; AmnealPharmaceuticals, Inc; Cipla Inc; Reckitt Benckiser Group plc; SunPharmaceutical Industries Ltd; and Aurobindo Pharma Ltd are some of the prominentplayers operating in the chronic cough market. The market players are focused onorganic strategies to sustain their position in the market. For instance, in October,2019, Aurobindo Pharma received final approval from the United States Food andDrug Administration (USFDA) to manufacture its generic Guaifenesinextended-release tablets in the strengths of 600 mg and 1,200 mg.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)@ https://www.theinsightpartners.com/sample/TIPRE00011584/?utm_source=opr%2F10291

The growth of the market isattributed to the factors such as increase in rising incidences of chroniccough and growing product developments to treat chronic cough. On the otherhand, product recall is the major factor likely to restraint the market growthduring the forecast period.

Market Insights

Rising Incidences of Chronic Cough

Drug Class Insights- Drug Class Insights- Chronic cough is caused due to asthma, acid reflux from the stomach,and postnasal drip. The conditions such as infection, bronchitis, and lungdiseases are also likely to lead to chronic cough.

Based on drug class, the chronic cough market is segmented into antihistamines,corticosteroids, decongestants, combination drug, antibiotics, acid blockers,and other drug class. The combination drug segment held the largest share ofthe market in 2019 and the same segment is estimated to report the highest CAGRin the market during the forecast period.

Route ofAdministration Insights- Based on rout of administration, the chronic cough market is segmentedinto oral, injections, inhalation, and other route of administration. The oral segmentheld the largest share of the market in 2019.

Table of Content:

Introduction
Chronic Cough Market – Key Takeaways
Research Methodology
Chronic Cough Market – Market Landscape
Chronic Cough Market – Key Market Dynamics
Chronic Cough Market – Global Analysis
Chronic Cough Market Analysis – By Drug Class
Chronic Cough Market – By Route of Administration
Chronic Cough Market – By Distribution Channel
Chronic Cough Market – Geographic Analysis
Impact of COVID-19 Pandemic on Global Chronic cough Market
Chronic Cough Market –Industry Landscape
COMPANY PROFILES
Appendix

Global Chronic Cough Market – By Drug Class

Antihistamines
Corticosteroids
Decongestants
Combination Drug
Antibiotics
Acid Blockers
Other Drug Class

Global Chronic CoughMarket– By Route of Administration

Oral
Injections
Nasal
OtherRoute of Administration

Global ChronicCough Market– By Distribution Channel

HospitalPharmacy
OnlinePharmacy
RetailPharmacy

Chronic Cough Market– By Geography

North America
Europe
Asia Pacific (APAC)
Middle East and Africa (MEA)
South and Central America

Read complete report along with TOC @ https://www.theinsightpartners.com/buy/TIPRE00011584/?utm_source=opr%2F10291

Contact Us:

For More Information Kindly Contact:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.